An Analysis of the Medical Costs of and Factors Affecting Diabetes Using the Medical Checkup and Payment Dataset in Japan: Can We Reduce the Prevalence of Diabetes?

Abstract

Background: The cost and economic burden of diabetes are a serious worldwide issue. In this study, we evaluated medical payments for persons diagnosed with diabetes and the factors that led to a person having diabetes to reduce its prevalence. Methods: A dataset containing 113,979 medical checkups and 3,671,783 monthly medical, dental, care-giving and pharmacy payment records of one health insurance society was used. The dataset contains information of normal and healthy persons. The sample period ran from April, 2013 to March, 2016. The medical payments for persons diagnosed with diabetes were calculated. The regression analysis was used to remove the effects of age and gender. The probit analysis was used to analyze the factors that led to a person having diabetes. Results: In 2.9% of cases, the person undergoing the checkup was diagnosed with diabetes, and the medical payments for these patients were 2.7 times as much as the average medical payment per person. This result did not change significantly even if age and gender were considered. The results of the probit analysis suggested that body mass index, high systolic blood pressure, low diastolic blood pressure, eating habits, physical activities, smoking, drinking alcohol and sleeping were important factors for diabetes. Conclusion: The diabetes might be a costlier disease than previously thought in Japan. By the estimation, 8% of all medical payments were made for these persons with diabetes, which is much higher than the result shown by national survey data. However, overall prevalence could be recused by efforts such as prevention of overweight and obesity.

Does High Systolic Blood Pressure Truly Increase Medical Expenditure?—An Empirical Analysis of the New 2017 ACC/AHA Hypertension Guideline

“…This model did not include variables related to anamnesis, currently treated diseases, or individual lifestyles. For example,hypertension is an important risk factor of diabetes[51]. Suppose that the relation may be "hypertension = > diabetes = > medical expenditure".…”

Healthcare resource utilization and healthcare costs in patients with type 2 diabetes mellitus initiating sodium‐glucose cotransporter 2 inhibitors vs dipeptidyl peptidase‐4 inhibitors in Japan: A real‐world administrative database analysis

“…Despite advances in treatment and prevention efforts, the economic burden in patients with diabetes mellitus remains high, both globally and in Japan [1][2][3][4] . The total costs of diabetes were 1.3 trillion US dollars (USD) in 2015 and are expected to increase to 2.1 trillion USD by 2030 1 .…”

Evaluation of Blood Pressure Control Medicines Using Health and Medical Checkup Data in Japan: Alternative Methods for Randomized Controlled Trials

“…According to the Ministry of Health, Welfare, and Labor, medical expenditures for high BP and related diseases were 1.85 trillion yen, accounting for 4.36% of total medical expenditures (42.36 trillion yen) in fiscal year 2015 in Japan [2]. Moreover, hypertension increases the medical expenditures of patients with other diseases such as diabetes [3] [4] [5], reduces happiness and life satisfaction [6] [7], and the true cost of hypertension is considered to be much higher than the direct cost.…”